Sponsor pipeline

Beacon Therapeutics clinical trial pipeline

Get alerts when Beacon Therapeutics's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 2
3
Phase 2/3
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2/3
NCT04850118 A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of… X-Linked Retinitis Pigmentosa Active, Not Recruiting 2026-04-07
Phase 2
NCT07174726 A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec… X-Linked Retinitis Pigmentosa (XLRP) Active, Not Recruiting 2026-06-25
NCT06275620 A Study Comparing Two Doses of AGTC-501 in Male Participants With X-linked Retinitis… X-Linked Retinitis Pigmentosa Enrolling by Invitation 2024-10-30
NCT06333249 A Study Comparing Two Doses of AGTC-501 in Male Subjects With X-linked Retinitis… X-Linked Retinitis Pigmentosa Active, Not Recruiting 2024-08-12
Get alerts when Beacon Therapeutics's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free